Rhausler

Executive Summary

Rhausler Inc. is a privately-held medical device company headquartered in San Francisco, California, specializing in innovative implantable systems for cervical spine surgery. Founded by a neurosurgeon in 2019, the company has developed FDA-cleared products including dynamic cervical plates and the integrated PLAGE fusion system, which have been used in over 5,000 patient cases. These products aim to provide a less invasive and easier-to-use alternative to traditional cervical plating and fusion procedures, addressing a significant need in spine surgery. Rhausler's surgeon-founded approach ensures deep clinical insight, and its growing commercial traction reflects strong surgeon adoption. The global cervical spine surgery market is expanding due to an aging population and increasing prevalence of degenerative disc disease. Rhausler's differentiated product portfolio, which combines dynamic stabilization with fusion technology, positions it to capture share from established competitors. With a focus on training and clinical evidence generation, the company is well-positioned for continued growth. Near-term catalysts include the expansion of its PLAGE system through surgical education programs, potential FDA clearance for next-generation devices, and a possible strategic partnership to broaden market access.

Upcoming Catalysts (preview)

• 2026 Q3Expansion of PLAGE Fusion System Sales Through Surgical Training Programs70% success
• 2026 Q4FDA Clearance for Next-Generation Dynamic Cervical Plate60% success
• TBDStrategic Partnership or Distribution Agreement with Major Orthopedic Company50% success